Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa, 226-8503, Japan.
Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa, 226-8503, Japan.
Pharm Res. 2023 Jan;40(1):157-165. doi: 10.1007/s11095-022-03414-8. Epub 2022 Oct 28.
Controlling small interfering RNA (siRNA) activity by external stimuli is useful to exert a selective therapeutic effect at the target site. This study aims to develop a technology to control siRNA activity in a thermo-responsive manner, which can be utilized even at temperatures close to body temperature.
siRNA was conjugated with a thermo-responsive copolymer that was synthesized by copolymerization of N-isopropylacrylamide (NIPAAm) and hydrophilic N,N-dimethylacrylamide (DMAA) to permit thermally controlled interaction between siRNA and an intracellular gene silencing-related protein by utilizing the coil-to-globule phase transition of the copolymer. The composition of the copolymer was fine-tuned to obtain lower critical solution temperature (LCST) around body temperature, and the phase transition behavior was evaluated. The cellular uptake and gene silencing efficiency of the copolymer-siRNA conjugates were then investigated in cultured cells.
The siRNA conjugated with the copolymer with LCST of 38.0°C exhibited ~ 11.5 nm of the hydrodynamic diameter at 37°C and ~ 9.8 nm of the diameter at 41°C, indicating the coil-globule transition above the LCST. In line with this LCST behavior, its cellular uptake and gene silencing efficiency were enhanced when the temperature was increased from 37°C to 41°C.
By fine-tuning the LCST behavior of the copolymer that was conjugated with siRNA, siRNA activity could be controlled in a thermo-responsive manner around the body temperature. This technique may offer a promising approach to induce therapeutic effects of siRNA selectively in the target site even in the in vivo conditions.
通过外部刺激控制小干扰 RNA(siRNA)的活性有助于在靶位发挥选择性治疗作用。本研究旨在开发一种技术,以热敏的方式控制 siRNA 的活性,即使在接近体温的温度下也可以利用该技术。
将 siRNA 与热敏共聚物缀合,该共聚物由 N-异丙基丙烯酰胺(NIPAAm)和亲水 N,N-二甲基丙烯酰胺(DMAA)共聚合成,通过利用共聚物的从线圈到球的相转变,使 siRNA 与细胞内与基因沉默相关的蛋白质之间能够进行热控相互作用。精细调整共聚物的组成以获得接近体温的低临界溶液温度(LCST),并评估其相转变行为。然后在培养的细胞中研究共聚物-siRNA 缀合物的细胞摄取和基因沉默效率。
LCST 为 38.0°C 的 siRNA 与共聚物缀合后,在 37°C 下表现出约 11.5nm 的水动力直径,在 41°C 下表现出约 9.8nm 的直径,表明在 LCST 以上发生了从线圈到球的转变。与这种 LCST 行为一致,当温度从 37°C 升高到 41°C 时,其细胞摄取和基因沉默效率均得到提高。
通过精细调整与 siRNA 缀合的共聚物的 LCST 行为,可以在接近体温的热敏方式下控制 siRNA 的活性。该技术可能为在体内条件下选择性地在靶位诱导 siRNA 的治疗效果提供一种有前途的方法。